Le Lézard
Classified in: Ebola virus, Health, Science and technology
Subjects: BFA, VDM

Academician discusses healthcare advances over 70 years


BEIJING, Sept. 16, 2019 /PRNewswire/ -- A news report by China Daily discussing healthcare advances over 70 years in China:

The life expectancy of Chinese people has risen from just 35 years to over 77 since the People's Republic of China was founded, owing to great efforts of China to control diseases and improve healthcare systems.

In addition, it has also assisted Africa to deal with fatal plagues such as Ebola.

Watch the video of Gao Fu, head of the Chinese Center for Disease Control and Prevention, and see how China has managed to achieve remarkable results for the welfare of its citizens.

This video is the second in our series China at 70.

SOURCE China Daily


These press releases may also interest you

18 mai 2024
Reality TV Star, Mollie Pearce, Backs Campaign to Tackle Inequalities in Condition That Impacts Millions of People Globally
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
Industrial Automation Market In Life Sciences Industry size is set to grow by USD 5.06 bn from 2024-2028, growing global demand for healthcare services to boost the market growth, Technavio
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
Ibbaka Revenue Retention Maturity Model Helps B2B SaaS Companies Uncover Hidden Opportunities Within Customer Revenue Growth
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals' LIVMARLI Data Showcased at ESPGHAN Annual Meeting
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

18 mai 2024
After Launching Massive Camp Giveaway for NYC Families Affected by "Summer Rising" Crisis, Brains & Motion Education (BAM!) Extends Initiative to SF Bay Area Families
After tens of thousands of NYC children were turned away from "Summer Rising," New York City's popular, free summer enrichment program, Brains & Motion launched a campaign offering camps at NYU for a small fraction of the up-to-$1400 per week price...

More news about Science and technology...


News published on and distributed by: